Skip to main content
Aric Hall, MD, Oncology, Madison, WI

AricCameronHallMD

Oncology Madison, WI

Assistant Professor / Attending Physician in Hematology and Bone Marrow Transplant, University of Wisconsin Hospital and Clinics

Dr. Hall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hall's full profile

Already have an account?

  • Office

    600 Highland Ave
    Madison, WI 53792
    Phone+1 608-265-1700

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2008 - 2011
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2008

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2012 - 2025
  • MA State Medical License
    MA State Medical License 2011 - 2014

Publications & Presentations

PubMed

Abstracts/Posters

  • Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Di...
    Aric C. Hall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
    Aric C. Hall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Aric C. Hall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • User:AricHallMD
    User:AricHallMDOctober 15th, 2017

Professional Memberships